What is a ‘Provider Dependent’ Therapy?

 

Your Calmare treatment provider will make key decisions when using MC-5A scrambler therapy technology to reduce or eliminate your chronic pain. Therefore, it is essential to vet your provider.

 


 

By Dr. Michael J. Cooney, Clinical Director

Dr. Michael J. Cooney

The ultimate success of your Calmare Therapy depends on several measurable variables. In my opinion, other than being correctly pre-qualified as a patient candidate, the doctor administering the scrambler therapy will have the most critical impact on your overall pain management success using scrambler therapy.

Therefore, your Calmare provider must have extensive expertisetraining and clinical skill to accurately diagnose the precise location of the original pain site/s and set the MC-5A Calmare technology accurately to support pain relief.

Four essential Calmare provider skills
  1. Strategically positioning each of the scrambler therapy leads on the patient in accordance with the original injury and current pain regions
  2. Setting, overseeing and adjusting the device settings during each of the 10 treatments
  3. Managing and responding to ongoing patient feedback
  4. Monitoring day-by-day pain management levels based on patient input.

 I will be your Calmare provider, 100 percent of the time, from start to finish ─ no assistants, no support staff. 

The placement of the leads (patches), attached to each of the algorithms, as you can see below, must be precisely positioned in order to successfully alleviate the nerve pain.

If these leads are placed in the wrong area, this lessens the overall capability of the Calmare MC-5A technology to optimally perform its job of lowering your pain and lessening any related physical symptoms.

As a Calmare provider since 2011, I have treated more than 1,000 patients from around the world–successfully. I have also served as an expert Trainer for new doctors introducing Calmare.

This is a responsibility I take very seriously.

Key assets your Calmare clinician should possess
Clinical Director Dr. Michael Cooney places the scrambler therapy leads on a CRPS patient.

The most experienced Calmare Therapy providers have received a careful review and on-site examination by the company’s administrators, who may or may not designate the top providers as Calmare Certified. I strongly encourage you to seek out these providers for your therapy.

Secondly, ask the provider you are considering how many patients they have treated with your specific chronic pain condition ─ back and neck pain, post-surgical pain, RSD / CRPS / fibromyalgia, pain after chemotherapy, diabetic neuropathy, etc.

Your Calmare technology will be most successful when your chosen provider has advanced expertise in the placement of each lead. Finally, peruse the internet and read reviews about the provider you are considering.

Get firsthand information about what scrambler therapy is really like by connecting directly with our previous patients.
Speak with other Calmare Therapy clients

At Calmare NJ USA, we offer an exclusive program called the Patient-2-Patient program, where you can be in contact with one of our previous patients who has a similar medical condition to your own. Who better to share their Calmare treatment experiences than our own patients?

As a friendly reminder, I am happy to speak with people living with treatment-resistant chronic pain anytime. Feel free to call my office at (201) 933-4440 or email us at info@calmaretherapynj.com.

Wishing you and your loved ones a low pain day.

Dr. Michael Cooney

Share on facebook
Facebook
Share on linkedin
LinkedIn
Share on twitter
Twitter
Share on email
Email

CRPS | RSD

Neuropathic Pain

Pediatric Chronic Pain

Sciatica & Chronic Back Pain

Shingles Nerve Pain (PHN)

Dr. Cooney at Calmare personally consults with every potential scrambler therapy patient.

Reach out for a no-fee phone or video consultation with our clinical director this week!

Learn more about Calmare scrambler therapy on these pages and then discuss your case directly with Dr. Michael Cooney.